Using UNC's expertise to fight emerging diseases
Fri Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that.
Share: Facebook | Twitter | Email
Related: Campus Connections
Recent Campus Connections News:Incoming UNC graduate student runs across the country 4,000 miles for a causeTuesday July 17, 2018Best burger in U.S. is at Al's Burger Shack in Chapel HillMonday July 16, 2018Video: UNC doctors work to contain African Ebola outbreakMonday July 16, 2018Carolina Performing Arts receives $1.5 million grant from The Andrew W. Mellon FoundationFriday July 13, 2018From Chapel Hill to Bowie and Emmitsburg, A Life in the BoothFriday July 13, 2018